Exchange: NASDAQ·Updated 08:24 AM EDT
STTK logo

STTK Shattuck Labs Inc

$6.74
$0.17
(2.46%)
Pre-Market
Prev Close $6.91
Reported EarningsAug 11
Mkt Cap$693.51M
Vol102.00

About STTK

Shattuck Labs, Inc. is a clinical-stage biotechnology company, which engages in the research and development of potential treatments for inflammatory and immune-mediated diseases. It focuses on developing a potential first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company was founded by Josiah C. Hornblower and Taylor Schreiber in 2016 and is headquartered in Austin, TX.
42

Bearish Sentiment

How do you feel about STTK?

Advertisement|Remove ads.